While much of the global concern has subsided, COVID-19 is still a very real threat, especially to people with compromised immune systems or who are over 65.
Uni-Bio Science Group Limited Announces 2024 Interim Results – Biotech Investments
EQS Newswire / 28/08/2024 / 19:52 UTC+8 Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical